Fierce Pharma
OCTOBER 16, 2024
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from Gilead Sciences, the company has presented strong results from three real-world studies of its bi-monthly injection for HIV prevention.
MedCity News
OCTOBER 16, 2024
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight the shifting landscape of healthcare innovation in many different settings. Register today! The post 12 Compelling Sessions to Check Out at HLTH 2024 appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 16, 2024
As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and drug shortages have prompted a call for industrial action in the company’s | French unions have urged Sanofi employees to strike from the start of their shifts Thursday in a move covering “the whole of France." The industrial action hinges on concerns over job cuts and drug shortages tied to Sanofi's potential consumer health stake sale.
MedCity News
OCTOBER 16, 2024
Healthcare providers play a critical role in helping caregivers recognize potential imbalances. Encouraging caregivers to access resources for self-care and respite isn’t just a nicety, it’s a clinical necessity. The post Nurturing the Nurturers: The Role of Parental and Caregiver Wellness in Supporting Children’s Mental Health appeared first on MedCity News.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Fierce Pharma
OCTOBER 16, 2024
A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030. | A federal judge in Delaware has ruled in favor of Exelixis in its Cabometyx patent fight with MSN Laboratories, effectively pushing the earliest generic entry out to 2030.
MedCity News
OCTOBER 16, 2024
This new approach is helping payors and providers unlock new value from their VBC initiatives while offering more effective and condition-specific treatment for patients. The post Evolving Markets, Innovative Solutions: The Rise of Specialty VBC appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 16, 2024
The FDA approved Novocure medical device Optune Luna as a treatment for advanced cases of non-small cell lung cancer. The wearable technology delivers electrical fields that kill cancer cells. The post Wearable Tumor-Zapping Medical Device Wins FDA Approval for Lung Cancer appeared first on MedCity News.
Fierce Pharma
OCTOBER 16, 2024
Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to explore routes to maximize the company’s value. | Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to explore alternative routes for the drugmaker.
MedCity News
OCTOBER 16, 2024
In the future, healthcare AI startups that offer multimodal models may have an easier time raising venture capital than healthcare AI companies that don’t, according to Morgan Cheatham, vice president at Bessemer Venture Partners. The post How One Investor Views the Future of Healthcare AI appeared first on MedCity News.
pharmaphorum
OCTOBER 16, 2024
Pfizer partners with US biotech Triana Biomedicines in a deal focusing on molecular glue degraders that could be worth $1.
MedCity News
OCTOBER 16, 2024
Oshi Health’s $60 million Series C funding round was led by Oak HC/FT and included participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. The post Oshi Health Secures $60M To Scale Virtual Digestive Care appeared first on MedCity News.
pharmaphorum
OCTOBER 16, 2024
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.
European Pharmaceutical Review
OCTOBER 16, 2024
Three industry partners have agreed to collaborate to develop an intensified perfusion process for manufacturing adeno-associated virus (AAV) vectors, leading to improved gene therapy production. The two-year project is supported by a £1.4 million grant through the Innovate UK Transforming Medicines Manufacturing (TMM) Programme, and involves the Cell and Gene Therapy (CGT) Catapult , Pharmaron Biologics (UK) Ltd and Complement Therapeutics.
pharmaphorum
OCTOBER 16, 2024
Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD)
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
PharmExec
OCTOBER 16, 2024
In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.
pharmaphorum
OCTOBER 16, 2024
NIH study finds Bavarian Nordic's mpox vaccine is effective in adolescents, a particularly vulnerable group amid the ongoing outbreak
PM360
OCTOBER 16, 2024
The service includes more than 50 healthcare influencers in 14 therapeutic areas who will develop relevant and engaging content for clients. by Jack O’Brien, MM+M October 15, 2024 Share article on Twitter Share article on Facebook Share article on LinkedIn (Photo credit: Getty Images/Ignatiev). NEW YORK: Havas Lynx launched a global health influencer offering last Friday, formalizing its organic community of content creators to better communicate with healthcare professionals and patients
Evolve Your Success
OCTOBER 16, 2024
From an internship to a full-time role at GE Healthcare, Marie Robert’s journey is anything but typical. Join us as Marie, a spirited product sales specialist, opens up about her transition from a pre-med student to thriving in the medical device sales industry, with a focus on anesthesia and perioperative equipment. Her story is a testament to the power of building strategic relationships and navigating the complexities of selling capital equipment where decision-makers are not always the
Clarify Health
OCTOBER 16, 2024
Deploying Analytics to Enable Primary Care Strategy A webinar with Clarify Health and Memorial Herman in collaboration with the American Association of Physician Leadership (AAPL). “ Clarify’s platform allowed us to dive deep into our referral data and identify areas where we could better engage with providers. This, in turn, helped us strengthen those partnerships and expand our reach.
PharmExec
OCTOBER 16, 2024
Results from the Phase II/III Vibrance-MG study found that patients with generalized myasthenia gravis who were treated with nipocalimab plus standard-of-care achieved sustained disease control.
Clarivate
OCTOBER 16, 2024
Green trademarks are a powerful tool for businesses that seek to communicate their sustainability commitments to consumers. However, some businesses have also utilized these marks to influence consumer purchasing decisions without fully committing to the cause. As with all trademark applications, sustainability marks are subject to rigorous legal and regulatory scrutiny, and brand owners must navigate a complex landscape to ensure their eco-friendly claims are both genuine and legally sound.
Pharmaceutical Commerce
OCTOBER 16, 2024
In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Copyright Clearance Center
OCTOBER 16, 2024
October 16, 2024 – Kriyadocs is excited to announce a new strategic collaboration with CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, that features an integration of CCC’s Ringgold Identify Database , of organization persistent identifiers (PIDs) and metadata, into the Kriyadocs Unified Publishing Ecosystem. This partnership will support publishers in significantly enhancing data accuracy and streamlining the publishing process. “We are thrilled to
Curzon Consulting
OCTOBER 16, 2024
Highly Commended at the 2024 MCA Awards 16th October 2024 5 Minutes 10 Years of Continued Success Huge congratulations to the Curzon Consulting team – marking 10 years of continued success at last night’s MCA Awards. Amidst strong competition, we proudly secured a Highly Commended award in the Commercial Impact category. This outstanding achievement is a testament to the incredible work of the joint Marston Holdings and Curzon Consulting team, who delivered exceptional results within an im
PharmExec
OCTOBER 16, 2024
In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how CMOs can leverage artificial intelligence and other advanced analytics tools to extract meaningful insights and optimize marketing strategies.
Pharmaceutical Technology
OCTOBER 16, 2024
The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) is set to grow from sales of $11.5bn in 2023 to $30.8bn in 2033.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmExec
OCTOBER 16, 2024
Pharmaceutical companies are facing new guidelines, laws, and regulations requiring a reconsideration of how to prioritize, develop, commercialize, and ultimately, secure access to medicines.
Pharmaceutical Technology
OCTOBER 16, 2024
A new generation of remote monitoring devices in Scotland is helping to reduce the burden on healthcare systems and improve patient care.
PharmExec
OCTOBER 16, 2024
Results from the Phase III Vivid-1 trial found that more Crohn disease patients treated with mirikizumab achieved histologic response at week 52 compared to ustekinumab.
Pharmaceutical Commerce
OCTOBER 16, 2024
William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Expert insights. Personalized for you.
177 
Let's personalize your content